Cigna Accused of Prescription Drug Overcharging Scheme

Oct. 13, 2016, 6:54 PM

A new lawsuit accuses Cigna Corp. of a fraudulent overcharging scheme that caused health plan participants to pay more than 10 times the true cost of prescription drugs in some cases (Negron v. Cigna Corp., D. Conn., No. 3:16-cv-01702, complaint filed 10/13/16).

The proposed class action, filed Oct. 13 in a Connecticut federal court, alleges that the insurer forced in-network pharmacies to overcharge patients for prescription drugs and then clawed back the unauthorized overpayments for its own benefit. In some cases, the complaint alleges, patients paid $20 for a medication that cost Cigna less than $2, ...

To read the full article log in.

Learn more about a Bloomberg Law Subscription.